Developmental Neurotoxicity of Perfluorinated Chemicals Modeled in Vitro

Slotkin, Theodore A.; MacKillop, Emiko A.; Melnick, Ronald L.; Thayer, Kristina A.; Seidler, Frederic J.
June 2008
Environmental Health Perspectives;Jun2008, Vol. 116 Issue 6, p716
Academic Journal
BACKGROUND: The widespread detection of perfluoroalkyl acids and their derivatives in wildlife and humans, and their entry into the immature brain, raise increasing concern about whether these agents might be developmental neurotoxicants. OBJECTIVES: We evaluated perfluorooctane sulfonate (PFOS), perfluorooctanoic acid (PFOA), perfluorooctane sulfonamide (PFOSA), and perfluorobutane sulfonate (PFBS) in undifferentiated and differentiating PC12 cells, a neuronotypic line used to characterize neurotoxicity. METHODS: We assessed inhibition of DNA synthesis, deficits in cell numbers and growth, oxidative stress, reduced cell viability, and shifts in differentiation toward or away from the dopamine (DA) and acetylcholine (ACh) neurotransmitter phenotypes. RESULTS: In general, the rank order of adverse effects was PFOSA > PFOS > PFBS ≈ PFOA. However, superimposed on this scheme, the various agents differed in their underlying mechanisms and specific outcomes. Notably, PFOS promoted differentiation into the ACh phenotype at the expense of the DA phenotype, PFBS suppressed differentiation of both phenotypes, PFOSA enhanced differentiation of both, and PFOA had little or no effect on phenotypic specification. CONCLUSIONS: These findings indicate that all perfluorinated chemicals are not the same in their impact on neurodevelopment and that it is unlikely that there is one simple, shared mechanism by which they all produce their effects. Our results reinforce the potential for in vitro models to aid in the rapid and cost-effective screening for comparative effects among different chemicals in the same class and in relation to known developmental neurotoxicants.


Related Articles

  • Brain Effects Stick Around. Fields, Scott // Environmental Health Perspectives;Jun2008, Vol. 116 Issue 6, pA258 

    The article discusses the possible neurotoxic effects of perfluorinated chemicals. The researchers compared the neurotoxicity of perfluorooctane sulfonate (PFOS), perfluorooctanoic acid (PFOA), perfluorooctane sulfonamide (PFOSA), and perfluorobutane sulfonate (PFBS). They analyzed brain cell...

  • High content imaging quantification of multiple in vitro human neurogenesis events after neurotoxin exposure. Xian Wu; Majumder, Anirban; Webb, Robin; Stice, Steven L. // BMC Pharmacology & Toxicology;12/1/2016, Vol. 17, p1 

    Background: Our objective was to test neural active compounds in a human developmental neurotoxicity (DNT) model that represents neural tube stages of vulnerability. Previously we showed that 14 days in vitro (DIV 14) was sufficient to generate cryopreserved neuronal cells for post thaw neurite...

  • Molecular Pathology of Neuro-AIDS (CNS-HIV). Crews, Leslie; Patrick, Christina; Achim, Cristian L.; Everall, Ian P.; Masliah, Eliezer // International Journal of Molecular Sciences;Mar2009, Vol. 10 Issue 3, p1045 

    The cognitive deficits in patients with HIV profoundly affect the quality of life of people living with this disease and have often been linked to the neuro-inflammatory condition known as HIV encephalitis (HIVE). With the advent of more effective anti-retroviral therapies, HIVE has shifted from...

  • Methyl Mercury Exposure During Post-Natal Brain Growth Alters Behavioral Response to SCH 23390 in Young Rats. Pereira, M. E.; Morsch, V. M.; Christofari, R. S.; Rocha, J. B. T. // Bulletin of Environmental Contamination & Toxicology;Aug99, Vol. 63 Issue 2, p256 

    The article presents a study which examines the effects of methyl mercury treatment during the second stage of rapid post-natal brain growth on the behavioral response of 25-day-old rats to SCH 23390, a specific D1 dopamine receptor antagonist. Researchers have determined the rat's brain levels...

  • Workgroup Report: Incorporating In Vitro Alternative Methods for Developmental Neurotoxicity into International Hazard and Risk Assessment Strategies. Coecke, Sandra; Goldberg, Alan M.; Allen, Sandra; Buzanska, Leonora; Calamandrei, Gemma; Crofton, Kevin; Hareng, Lars; Hartung, Thomas; Knaut, Holger; Honegger, Paul; Jacobs, Miriam; Lein, Pamela; Li, Abby; Mundy, William; Owen, David; Schneider, Steffen; Silbergeld, Ellen; Reum, Torsten; Trnovec, Tomas; Monnet-Tschudi, Florianne // Environmental Health Perspectives;Jun2007, Vol. 115 Issue 6, p989 

    This is the report of the first workshop on Incorporating In Vitro Alternative Methods for Developmental Neurotoxicity (DNT) Testing into International Hazard and Risk Assessment Strategies, held in Ispra, Italy, on 19-21 April 2005. The workshop was hosted by the European Centre for the...

  • Pharmacology of botulinum neurotoxin serotype A. Wenzel, Richard G. // American Journal of Health-System Pharmacy;11/15/2004 Supplement 6, Vol. 61, pS5 

    Purpose. An historical perspective on the discovery and development of botulinum neurotoxin for commercial use, the differences between various botulinum toxin serotypes and commercially available products, and the structure, mechanism of action, pharmacologic effects, and immunogenicity of...

  • Binding of long-chain α-neurotoxin would stabilize the resting state of nAChR: A comparative study with α-conotoxin. Nasiripourdori, Adak; Ranjbar, Bijan; Hossein Naderi-Manesh // Theoretical Biology & Medical Modelling;2009, Vol. 6, p1 

    Background: The details of interaction in a complex between potent antagonists such as long chain α-neurotoxins and α-conotoxins with nicotinic acetylcholine receptor (nAChR), and conformational changes induced by these antagonists, are not yet clear. Modeling: In order to uncover some of...

  • In vivo neurochemical characterization of Anatoxin-a evoked dopamine release from striatum. Campos, F.; Durán, R.; Vidal, L.; Faro, L. R. F.; Alfonso, M. // Journal of Neural Transmission;Feb2007, Vol. 114 Issue 2, p173 

    Anatoxin-a (AnTx) is a natural neurotoxin, which acts as a potent and stereoselective agonist at the nicotinic acetylcholine receptors. The in vivo actions of the AnTx on dopamine (DA) release are scarcely characterized. The aim of this study was to determine the neurochemical bases for...

  • LRRK2 regulates synaptogenesis and dopamine receptor activation through modulation of PKA activity. Parisiadou, Loukia; Yu, Jia; Sgobio, Carmelo; Xie, Chengsong; Liu, Guoxiang; Sun, Lixin; Gu, Xing-Long; Lin, Xian; Crowley, Nicole A; Lovinger, David M; Cai, Huaibin // Nature Neuroscience;Mar2014, Vol. 17 Issue 3, p367 

    Leucine-rich repeat kinase 2 (LRRK2) is enriched in the striatal projection neurons (SPNs). We found that LRRK2 negatively regulates protein kinase A (PKA) activity in the SPNs during synaptogenesis and in response to dopamine receptor Drd1 activation. LRRK2 interacted with PKA regulatory...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics